Luca G Guidotti

12PUBLICATIONS
99CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 04, 2026
IFNAR1 stabilization sustains CD8+ T cell persistence in IFN-high colorectal cancer liver metastases.

|Aug 28, 2026
Platelet-derived serotonin drives age-related lung pathology in SARS-CoV-2 infection.

|Jun 30, 2025
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming.

Valentina Venzin, Cristian G Beccaria, Chiara Perucchini

|Apr 01, 2025
T-cell-derived IFN-γ suppresses T follicular helper cell differentiation and antibody responses.

Eleonora Sala, Maria Nelli, Chiara Laura

|Mar 15, 2024
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination.

Valeria Fumagalli, Micol Ravà, Davide Marotta

|Mar 22, 2023
Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses.

Valeria Fumagalli, Pietro Di Lucia, Micol Ravà

Pageof 2

Frequent Collaborators

9 joint publications

Matteo Iannacone

6 joint publications

Valeria Fumagalli

5 joint publications

Micol Ravà

5 joint publications

Mirela Kuka